FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048608437> ?p ?o ?g. }

• W3048608437 endingPage "1589" @default.
• W3048608437 startingPage "1579" @default.
• W3048608437 abstract "Abstract Aims SCN5A mutations are associated with arrhythmia syndromes, including Brugada syndrome, long QT syndrome type 3 (LQT3), and cardiac conduction disease. Long QT syndrome type 3 patients display atrio-ventricular (AV) conduction slowing which may contribute to arrhythmogenesis. We here investigated the as yet unknown underlying mechanisms. Methods and results We assessed electrophysiological and molecular alterations underlying AV-conduction abnormalities in mice carrying the Scn5a1798insD/+ mutation. Langendorff-perfused Scn5a1798insD/+ hearts showed prolonged AV-conduction compared to wild type (WT) without changes in atrial and His-ventricular (HV) conduction. The late sodium current (INa,L) inhibitor ranolazine (RAN) normalized AV-conduction in Scn5a1798insD/+ mice, likely by preventing the mutation-induced increase in intracellular sodium ([Na+]i) and calcium ([Ca2+]i) concentrations. Indeed, further enhancement of [Na+]i and [Ca2+]i by the Na+/K+-ATPase inhibitor ouabain caused excessive increase in AV-conduction time in Scn5a1798insD/+ hearts. Scn5a1798insD/+ mice from the 129P2 strain displayed more severe AV-conduction abnormalities than FVB/N-Scn5a1798insD/+ mice, in line with their larger mutation-induced INa,L. Transverse aortic constriction (TAC) caused excessive prolongation of AV-conduction in FVB/N-Scn5a1798insD/+ mice (while HV-intervals remained unchanged), which was prevented by chronic RAN treatment. Scn5a1798insD/+-TAC hearts showed decreased mRNA levels of conduction genes in the AV-nodal region, but no structural changes in the AV-node or His bundle. In Scn5a1798insD/+-TAC mice deficient for the transcription factor Nfatc2 (effector of the calcium-calcineurin pathway), AV-conduction and conduction gene expression were restored to WT levels. Conclusions Our findings indicate a detrimental role for enhanced INa,L and consequent calcium dysregulation on AV-conduction in Scn5a1798insD/+ mice, providing evidence for a functional mechanism underlying AV-conduction disturbances secondary to gain-of-function SCN5A mutations." @default.
• W3048608437 created "2020-08-18" @default.
• W3048608437 creator A5004368250 @default.
• W3048608437 creator A5011443582 @default.
• W3048608437 creator A5013163059 @default.
• W3048608437 creator A5016023161 @default.
• W3048608437 creator A5016568391 @default.
• W3048608437 creator A5022167195 @default.
• W3048608437 creator A5024969912 @default.
• W3048608437 creator A5033167666 @default.
• W3048608437 creator A5037475012 @default.
• W3048608437 creator A5041832482 @default.
• W3048608437 creator A5042843715 @default.
• W3048608437 creator A5045922112 @default.
• W3048608437 creator A5052780925 @default.
• W3048608437 creator A5054685260 @default.
• W3048608437 creator A5077749268 @default.
• W3048608437 creator A5090135028 @default.
• W3048608437 date "2020-08-10" @default.
• W3048608437 modified "2023-10-15" @default.
• W3048608437 title "Functional modulation of atrio-ventricular conduction by enhanced late sodium current and calcium-dependent mechanisms in <i>Scn5a1798insD/+</i> mice" @default.
• W3048608437 cites W1964124904 @default.
• W3048608437 cites W1991215300 @default.
• W3048608437 cites W1993471474 @default.
• W3048608437 cites W1999285273 @default.
• W3048608437 cites W2003284163 @default.
• W3048608437 cites W2006700820 @default.
• W3048608437 cites W2014020993 @default.
• W3048608437 cites W2053123139 @default.
• W3048608437 cites W2064461784 @default.
• W3048608437 cites W2072732939 @default.
• W3048608437 cites W2119327816 @default.
• W3048608437 cites W2124536475 @default.
• W3048608437 cites W2134905548 @default.
• W3048608437 cites W2139270980 @default.
• W3048608437 cites W2152220038 @default.
• W3048608437 cites W2156433522 @default.
• W3048608437 cites W2156580049 @default.
• W3048608437 cites W2157796632 @default.
• W3048608437 cites W2799476483 @default.
• W3048608437 cites W2801237521 @default.
• W3048608437 doi "https://doi.org/10.1093/europace/euaa127" @default.
• W3048608437 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7544532" @default.
• W3048608437 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32778883" @default.
• W3048608437 hasPublicationYear "2020" @default.
• W3048608437 type Work @default.
• W3048608437 sameAs 3048608437 @default.
• W3048608437 citedByCount "9" @default.
• W3048608437 countsByYear W30486084372021 @default.
• W3048608437 countsByYear W30486084372022 @default.
• W3048608437 countsByYear W30486084372023 @default.
• W3048608437 crossrefType "journal-article" @default.
• W3048608437 hasAuthorship W3048608437A5004368250 @default.
• W3048608437 hasAuthorship W3048608437A5011443582 @default.
• W3048608437 hasAuthorship W3048608437A5013163059 @default.
• W3048608437 hasAuthorship W3048608437A5016023161 @default.
• W3048608437 hasAuthorship W3048608437A5016568391 @default.
• W3048608437 hasAuthorship W3048608437A5022167195 @default.
• W3048608437 hasAuthorship W3048608437A5024969912 @default.
• W3048608437 hasAuthorship W3048608437A5033167666 @default.
• W3048608437 hasAuthorship W3048608437A5037475012 @default.
• W3048608437 hasAuthorship W3048608437A5041832482 @default.
• W3048608437 hasAuthorship W3048608437A5042843715 @default.
• W3048608437 hasAuthorship W3048608437A5045922112 @default.
• W3048608437 hasAuthorship W3048608437A5052780925 @default.
• W3048608437 hasAuthorship W3048608437A5054685260 @default.
• W3048608437 hasAuthorship W3048608437A5077749268 @default.
• W3048608437 hasAuthorship W3048608437A5090135028 @default.
• W3048608437 hasBestOaLocation W30486084371 @default.
• W3048608437 hasConcept C104397207 @default.
• W3048608437 hasConcept C118441451 @default.
• W3048608437 hasConcept C126322002 @default.
• W3048608437 hasConcept C134018914 @default.
• W3048608437 hasConcept C164705383 @default.
• W3048608437 hasConcept C2777382798 @default.
• W3048608437 hasConcept C2779703243 @default.
• W3048608437 hasConcept C2780040984 @default.
• W3048608437 hasConcept C71924100 @default.
• W3048608437 hasConceptScore W3048608437C104397207 @default.
• W3048608437 hasConceptScore W3048608437C118441451 @default.
• W3048608437 hasConceptScore W3048608437C126322002 @default.
• W3048608437 hasConceptScore W3048608437C134018914 @default.
• W3048608437 hasConceptScore W3048608437C164705383 @default.
• W3048608437 hasConceptScore W3048608437C2777382798 @default.
• W3048608437 hasConceptScore W3048608437C2779703243 @default.
• W3048608437 hasConceptScore W3048608437C2780040984 @default.
• W3048608437 hasConceptScore W3048608437C71924100 @default.
• W3048608437 hasFunder F4320320890 @default.
• W3048608437 hasFunder F4320321007 @default.
• W3048608437 hasFunder F4320321642 @default.
• W3048608437 hasIssue "10" @default.
• W3048608437 hasLocation W30486084371 @default.
• W3048608437 hasLocation W30486084372 @default.
• W3048608437 hasOpenAccess W3048608437 @default.
• W3048608437 hasPrimaryLocation W30486084371 @default.
• W3048608437 hasRelatedWork W118961461 @default.
• W3048608437 hasRelatedWork W1531601525 @default.
• W3048608437 hasRelatedWork W2076389702 @default.

• next